01 / DESIGN
What was studied?
A multicenter randomized study evaluated mazdutide against placebo in US adults with obesity or overweight without diabetes.
02 / FINDINGS
What did the researchers report?
Weight reduction exceeded placebo across the tested study groups, with different responses across the trial's escalation schedules.
03 / LIMITS
How should it be interpreted?
The primary analysis used a specified efficacy estimand and follow-up window. Cross-trial comparisons with other drugs are unreliable without accounting for populations, adherence and analysis methods.
Loti Labs Peptide editorial reading note. Based on the linked source record. Methods and corrections.